戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 oprovocations that demonstrated the variable extrathoracic airway obstruction of vocal cord dysfuncti
2 wanted therapeutic aerosol deposition at the extrathoracic airways.
3 e (18)F-FDG PET/MRI scans of 6 children with extrathoracic cancer before and after COVID-19 vaccinati
4  recurrence, NLSC, intrathoracic new cancer, extrathoracic cancer, or death measured using nonparamet
5  for intrathoracic new cancer, and 10.4% for extrathoracic cancer.
6 amma-camera scintigraphic images of lung and extrathoracic deposition were obtained within an asthmat
7 ast to the TV-ICD, the S-ICD is a completely extrathoracic device.
8 the plcD mutant were twice as likely to have extrathoracic disease as those infected by a strain with
9 rformance status 0 or 1, and all primary and extrathoracic disease controlled with local therapy.
10 nal dissemination, which was associated with extrathoracic disease recurrence, was found in 32% of ca
11                                              Extrathoracic dissemination of coccidioidomycosis is ass
12 gnancy, including nodular pleural effusions, extrathoracic dissemination, and osseous disease.
13 ation, cardiac morphology, intrathoracic and extrathoracic fat, and osteoporosis.
14  To this end, we describe and illustrate the extrathoracic imaging manifestations of COVID-19 in adul
15 on unnecessarily, it is crucial to know when extrathoracic imaging tests are indicated and which test
16 he non-Beijing/W lineage isolates to have an extrathoracic involvement (odds ratio [95% confidence in
17 pe was not associated with disease severity, extrathoracic involvement, or overall radiographic chang
18  bone marrow (chi(2) = 18.8, p < 0.001), and extrathoracic lymph node involvement (chi(2) = 7.21, p <
19 ed metastatic involvement (M1a or M1b due to extrathoracic lymph nodes only) or disseminated metastat
20  the lung is a common site for recurrence of extrathoracic malignancies.
21 dules were identified in eight patients with extrathoracic malignancies.
22                             The frequency of extrathoracic manifestations was higher in heart transpl
23                         (18)F-FDG identified extrathoracic metastases in 5 patients, excluding them f
24  for the nodal stage in 22 patients, and for extrathoracic metastases in 5 subjects.
25 al metastatic dissemination and tumours with extrathoracic metastases, and an association between hig
26  for the diagnosis and staging (thoracic and extrathoracic) of lung cancer.
27 tly higher possibility of developing initial extrathoracic-only recurrence than other types (P < .01)
28 transplant recipients involves the lungs and extrathoracic organs, tends to have an early onset, and
29                                           In extrathoracic organs, Vgamma2Vdelta2 T cells were locali
30 he transvenous ICD lead by using an entirely extrathoracic placement.
31 ious randomised trial of continuous negative extrathoracic pressure (CNEP) versus standard treatment
32      The decreased CPAP at the same negative extrathoracic pressure yielded a final lung volume incre
33 tive pressure attachment for manipulation of extrathoracic pressure.
34 nts (69 lung cancer, 25 mesothelioma, and 29 extrathoracic primary malignancies).
35 ng tumors (81% [25 of 31] of metastases from extrathoracic primary malignancies; median tumor size, 9
36                                              Extrathoracic PTLD occurred in 21 (68%) of 31 episodes a
37                                     Lung and extrathoracic radioaerosol deposition were quantified us
38 rathoracic recurrence in 22% (16 of 72), and extrathoracic recurrence in 18% (13 of 72) after 2 or mo
39                                          The extrathoracic region is found to have higher ROS concent
40 e the majority of spores deposit were in the extrathoracic region, there is a significant deposition
41 opy number heterogeneity was associated with extrathoracic relapse within 1 year after surgery.
42 d metastasized to multiple intrathoracic and extrathoracic sites in a pattern similar to that of huma
43 y involved other thoracic structures but not extrathoracic sites typical of other DLBCLs.
44 atients were eligible if they had SCLC or an extrathoracic small cell primary and 1-10 brain metastas
45 rom the left upper lobe of the lung into the extrathoracic soft tissues beneath the left upper pector
46 ociation appeared to differ with the type of extrathoracic TB.
47 racic TB than it does in the pathogenesis of extrathoracic TB.
48 r the previously identified risk factors for extrathoracic tuberculosis (human immunodeficiency virus
49  gene remained significantly associated with extrathoracic tuberculosis (odds ratio, 3.27; 95% confid
50                                              Extrathoracic tuberculosis is statistically significantl
51 her three plc genes are also associated with extrathoracic tuberculosis remains to be assessed.
52  features that facilitate the development of extrathoracic tuberculosis.
53 cD gene is associated with the occurrence of extrathoracic tuberculosis.